Medpace MEDP 深 滬
等待開盤 03-26 09:30:00 美东时间
466.80
+6.060
+1.32%
華盛通- 最 高471.91
- 今 開465.61
- 成交量 39.78万股
- 最 低 460.33
- 昨 收 460.74
- 總市值 132.48亿
- 52周最高 628.9155
- 市盈率 靜 30.55
- 換手率 1.40%
- 52周最低 250.05
- 委 比 -54.29%
- 總股本 2838.13万
- 歷史最高 628.9155
- 量 比 1.26
- 振 幅 2.51%
- 歷史最低 21.76
- 每 手 1
- 風險率 113.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Zelluna FY2025 annual report published; cash and cash equivalents climb to NOK 78 million
Zelluna FY2025 annual report published; cash and cash equivalents climb to NOK 78 million Zelluna’s annual report outlines progress toward first-in-human testing of its TCR-NK platform, with the lead program ZI-MA4-1 advancing through GMP manufacturing and clinical trial preparations. The company su
03-25 14:28
Zelluna selects Medpace as CRO for ZIMA-101 Phase 1 trial
Zelluna selects Medpace as CRO for ZIMA-101 Phase 1 trial Zelluna selected Medpace as its contract research organization to support the first-in-human Phase 1 trial of ZI-MA4-1 (ZIMA-101). Medpace will provide clinical operations and trial management, as well as regulatory support. The study will ev
03-17 15:48
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
As part of a broader review of life science and diagnostic tools stocks, Barclays upgraded contract research organizations IQVIA Holdings (IQV) and Medpace Holdings (MEDP) on Friday, noting that conce...
03-07 02:44
美股大行评级 | 绩后暴跌超22%，MongoDB遭14家大行集团下调目标价；挪威邮轮、阿莎娜、Quantum Computing等也遭大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NRX Pharmaceuticals"买入"评级，目标价从40美元升至45美元；RBC Capital：维持NUVATION BIO"跑赢大市"评级，目标价从12美元升至13美元
03-04 10:22
RBC Capital Initiates Coverage On Medpace Holdings with Outperform Rating, Announces Price Target of $522
RBC Capital analyst Ryan Halsted initiates coverage on Medpace Holdings (NASDAQ:MEDP) with a Outperform rating and announces Price Target of $522.
03-03 23:23
美股大行评级 | 潜在涨幅216.49%！杰富瑞上调BioAge Labs目标价至62美元，评级升至"买入"
今日重点评级关注：杰富瑞：上调BioAge Labs评级至"买入"，目标价从9美元升至62美元；RBC Capital：维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级，目标价从21美元升至22美元
02-19 16:21
TD Cowen Upgrades Medpace Holdings to Hold, Lowers Price Target to $419
TD Cowen analyst Charles Rhyee upgrades Medpace Holdings (NASDAQ:MEDP) from Sell to Hold and lowers the price target from $462 to $419.
02-19 02:39
华尔街顶级机构最新评级：帕兰提尔获上调，Workday遭下调
五大上调评级 瑞穗将帕兰提尔（PLTR）评级从中性上调至跑赢大盘，目标价 195 美元不变。该行称公司实现总收入增长、增速加快与利润率扩张，“规模表现是软件行...
02-18 23:06
Levi & Korsinsky Probes Medpace Holdings Over Securities Claims
Levi & Korsinsky Probes Medpace Holdings Over Securities Claims Levi & Korsinsky has opened an investigation into Medpace Holdings over potential securities law claims, focusing on whether the company misrepresented the health of its clinical-trial bookings pipeline amid elevated cancellations and a
02-18 22:02
U.S. RESEARCH ROUNDUP- Applied Materials, Humana, Gilead
U.S. RESEARCH ROUNDUP- Applied Materials, Humana, Gilead Feb 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, Humana and Gilead, on Friday. HIGHLIGHTS * 10X Genomics Inc TXG.O : JP Morgan raises targ
02-13 14:43
